8-A12B 1 t1501385_8-a12b.htm FORM 8-A12B

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934

RITTER PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State of incorporation or organization)
20-1295171
(I.R.S. Employer Identification No.)

 

1801 Century Park East Suite 1820
Los Angeles, California 90067
(Address of principal executive offices) (Zip Code)

 

Securities to be register to Section 12(b) of the Act:

 

Title of each class
to be so registered:
Name of each exchange on which each class is to be registered:
Common Stock, $0.001 Par Value The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.

Securities Act registration statement file number to which this form relates: 333-202924

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

 
 

 

ITEM 1.     DESCRIPTION OF REGISTRANT’S SECURITIES TO BE REGISTERED

Ritter Pharmaceuticals, Inc. (the “Registrant”) hereby incorporates by reference herein the description of its Common Stock, par value $0.001 per share, to be registered hereunder, contained under the heading “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-1 (File No. 333-202924), as originally filed with the Securities and Exchange Commission (the “Commission”) on March 23, 2015, including exhibits, and as amended from time to time thereafter (the “Registration Statement”). In addition, the above-referenced description included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

ITEM 2.     EXHIBITS

In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 
 

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.

Dated: June 12, 2015

  RITTER PHARMACEUTICALS, INC.
   
  By:  /s/ Michael D. Step
    Michael D. Step, Chief Executive Officer